The {pharmaceutical industry is increasingly exploring novel treatment strategies for obesity , and the arrival of semaglutide 10mg doses represents a advancement . Clinicians semaglutide 10mg vial are now consider the potential benefits and risks associated with this higher potency version , especially in relation to existing lower-dose semaglutid